Genetic factors contributing to late adverse musculoskeletal effects in childhood acute lymphoblastic leukemia survivors.
Shalmiev A, Nadeau G, Aaron M, Ouimet-Grennan E, Drouin S, Bertout L, Beaulieu P, St-Onge P, Veilleux LN, Rauch F, Rezgui A, Petrykey K, Laverdière C, Sinnett D, Alos N, Krajinovic M.
Shalmiev A, et al. Among authors: veilleux ln.
Pharmacogenomics J. 2022 Feb;22(1):19-24. doi: 10.1038/s41397-021-00252-6. Epub 2021 Aug 26.
Pharmacogenomics J. 2022.
PMID: 34446917